The Journal of Bone and Joint Surgery (American). 2005;87:842-849.
doi:10.2106/JBJS.C.01222
© 2005 The Journal of Bone and Joint Surgery, Inc.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the exams for this article:
 CME 2: April, May, June 2005
Oncology Test 4: Spring 2006 (publication date May 15, 2006; expiration dat...
Oncology Test 3: Spring 2006 (publication date May 15, 2006; expiration dat...
Right arrow [Supplementary Material]
Right arrow Letters to the Editor: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Letters to the Editor are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowReprints and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jeys, L.M.
Right arrow Articles by Tillman, R.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jeys, L.M.
Right arrow Articles by Tillman, R.M.
Related Collections
Right arrow Oncology
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Technorati  
What's this?

Periprosthetic Infection in Patients Treated for an Orthopaedic Oncological Condition

L.M. Jeys, MRCS, MSc(Orth)Eng1, R.J. Grimer, FRCS(Orth)2, S.R. Carter, FRCS2 and R.M. Tillman, FRCS(Orth)2

1 Waterstones House, 31a Green Abbey, Hade Edge, Holmfirth, West Yorkshire HD9 2SH, United Kingdom. E-mail address: lee.jeys{at}btclick.com
2 Royal Orthopaedic Hospital Oncology Service, Bristol Road South, Northfield, Birmingham B31 2AP, United Kingdom

Investigation performed at the Royal Orthopaedic Hospital Oncology Service, Northfield, Birmingham, United Kingdom

The authors did not receive grants or outside funding in support of their research or preparation of this manuscript. They did not receive payments or other benefits or a commitment or agreement to provide such benefits from a commercial entity. No commercial entity paid or directed, or agreed to pay or direct, any benefits to any research fund, foundation, educational institution, or other charitable or nonprofit organization with which the authors are affiliated or associated.

Background: Prosthetic replacement following excision of a bone tumor can be complicated by infection because patients who undergo surgery for a neoplastic condition often are subjected to extensive soft-tissue dissection and long operating times and are immunosuppressed. The aim of this study was to investigate the rate of periprosthetic infection, identify possible predisposing factors, and assess treatment efficacy in such patients.

Methods: Prosthetic reconstruction was performed in 1264 patients over a thirty-seven-year period in a single hospital by four surgeons. Twenty-four patients were excluded because of incomplete follow-up, leaving 1240 patients who had been followed for a mean of 5.8 years. Infection was identified in 136 patients (11.0%). The management and outcome of the infections in all of these patients were analyzed.

Results: Coagulase-negative Staphylococcus was the most common organism isolated. Two-stage revision successfully treated the infection in 72% (forty-two) of the fifty-eight patients in whom it was performed. Local surgical débridement with or without antibiotic implants was successful in only 6% (four) of sixty-eight patients. Amputation to treat the infection was performed in fifty (37%) of the 136 patients. The factors that were associated with a significant risk of infection (p ≤ 0.05) included tibial and pelvic prosthetic replacements, radiation therapy, and the use of a pediatric expandable prosthesis.

Conclusions: Patients treated with an orthopaedic procedure for an oncological condition have high infection rates. The treatment of infection in these patients is arduous and lengthy, with a substantial risk of amputation.

Level of Evidence: Prognostic Level II. See Instructions to Authors for a complete description of levels of evidence.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 JBJSHome page
L.M. Jeys, A. Kulkarni, R.J. Grimer, S.R. Carter, R.M. Tillman, and A. Abudu
Endoprosthetic Reconstruction for the Treatment of Musculoskeletal Tumors of the Appendicular Skeleton and Pelvis
J. Bone Joint Surg. Am., June 1, 2008; 90(6): 1265 - 1271.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Surg. Oncol.Home page
L. M. Jeys, R. J. Grimer, S. R. Carter, R. M Tillman, and A. Abudu
Post Operative Infection and Increased Survival in Osteosarcoma Patients: Are They Associated?
Ann. Surg. Oncol., October 1, 2007; 14(10): 2887 - 2895.
[Abstract] [Full Text] [PDF]